Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
Bristol-Myers Squibb
Filamon LTD
PMV Pharmaceuticals, Inc
Mayo Clinic
National Institutes of Health Clinical Center (CC)
UMC Utrecht
University of California, Irvine
ViroMissile, Inc.
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
University of Florida
Tizona Therapeutics, Inc
Essen Biotech
Clasp Therapeutics, Inc.
Ulsan University Hospital
Baylor College of Medicine
University of Colorado, Denver
Poitiers University Hospital
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Alliance for Clinical Trials in Oncology
SystImmune Inc.
Daiichi Sankyo
Institut Curie
University of Nebraska
EXoPERT
University of Michigan Rogel Cancer Center
Kidney Cancer Research Bureau
Adela, Inc
Eli Lilly and Company
NRG Oncology
NRG Oncology
Medical College of Wisconsin
Sichuan Baili Pharmaceutical Co., Ltd.
Var2 Pharmaceuticals
Mayo Clinic
Shanghai Juncell Therapeutics
University of Washington
City of Hope Medical Center
AdventHealth
Jonsson Comprehensive Cancer Center
Mayo Clinic
Brown University
UNC Lineberger Comprehensive Cancer Center
University of Calgary
LigaChem Biosciences, Inc.
British Columbia Cancer Agency